EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Botulinum Toxin for the Treatment of Motor Tics in Children: A Case Series

Ethan Edmondson iD, Mariam Hull, Sukru Aras, Mered Parnes

Journal of Child Neurology · 2026

DOI: 10.1177/08830738251360210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child Neurology, 2026. Verfasst von Ethan Edmondson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Movement Disorders Clinic, Section of Pediatric Neurology and Developmental Neuroscience, Texas Children's Hospital and Baylor College of M…. Hauptthemen laut MEDLINE: Tic Disorders, Tics, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tic disorders, including Tourette syndrome, are characterized by brief, repetitive, and patterned movements or vocalizations. Botulinum neurotoxin (BoNT) has emerged as a therapeutic option for motor tics, particularly when oral medications are insufficient or poorly tolerated. This retrospective cohort study evaluated the safety and effectiveness of botulinum neurotoxin injections in 50 pediatric patients (aged 7-18 years) with motor tic disorders treated at a tertiary pediatric movement disorders clinic between May 2019 and January 2024. Botulinum neurotoxin injections were tailored to individual symptomatology. Overall, 64% of patients reported improvement in tic severity, 36% noted no change, and 6% worsened. Response did not differ significantly by tic complexity, phenomenology (clonic vs dystonic), or presence of a premonitory urge. Comorbidities such as attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder, autism, and intellectual disability were not predictive of outcomes. These findings support botulinum neurotoxin as a safe and potentially effective treatment for pediatric motor tics, including complex and malignant presentations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tic DisordersTicsBotulinum Toxins, Type ANeuromuscular AgentsBotulinum ToxinsHumansChildMaleFemaleAdolescentRetrospective StudiesTreatment OutcomeTourette Syndrome

Stichwörter der Autor:innen

Tourette syndromepediatricquality of lifetreatment

Substanzen

Botulinum Toxins, Type ANeuromuscular AgentsBotulinum Toxins

Autor:innen und Institutionen

  • Pediatric Movement Disorders Clinic, Section of Pediatric Neurology and Developmental Neuroscience, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
  • Department of Pediatrics-Neurology Bioinformatics, Baylor College of Medicine, Houston, TX, USA.

ORCID-Profile: Ethan Edmondson

Zitieren

APA

Edmondson, E., Hull, M., Aras, S., & Parnes, M. (2026). Botulinum Toxin for the Treatment of Motor Tics in Children: A Case Series. Journal of Child Neurology. https://doi.org/10.1177/08830738251360210

Vancouver

Edmondson E, Hull M, Aras S, Parnes M. Botulinum Toxin for the Treatment of Motor Tics in Children: A Case Series. Journal of Child Neurology. 2026. doi:10.1177/08830738251360210

BibTeX
@article{Edmondson2026,
  author = {Edmondson, Ethan and Hull, Mariam and Aras, Sukru and Parnes, Mered},
  title = {Botulinum Toxin for the Treatment of Motor Tics in Children: A Case Series},
  journal = {Journal of Child Neurology},
  year = {2026},
  doi = {10.1177/08830738251360210}
}
Kostenlos starten →